Effect of a pharmacist-led educational intervention on clinical outcomes: a randomised controlled study in patients with hypertension, type 2 diabetes and hypercholesterolaemia

The clinical effects of a carbohydrate-reduced high-protein diet on glycaemic variability in metformin-treated patients with type 2 diabetes mellitus: A randomised controlled study

Clinical Nutrition ESPEN ◽

10.1016/j.clnesp.2020.07.002 ◽

2020 ◽

Vol 39 ◽

pp. 46-52

Author(s):

Mads N. Thomsen ◽

Mads J. Skytte ◽

Arne Astrup ◽

Carolyn F. Deacon ◽

Jens J. Holst ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

High Protein Diet ◽

Controlled Study ◽

Clinical Effects ◽

Glycaemic Variability ◽

Review for "Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomised controlled study (PRIME‐V study)"

10.1111/dom.13750/v1/review5 ◽

2019 ◽

Author(s):

Christine Mermier

Keyword(s):

Type 2 Diabetes ◽

Visceral Fat ◽

Japanese Patients ◽

Controlled Study ◽

Metabolic Dysfunction ◽

Open Label ◽

Fat Reduction ◽

Review for "Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomised controlled study (PRIME‐V study)"

10.1111/dom.13750/v2/review2 ◽

2019 ◽

Author(s):

Christine Mermier

Keyword(s):

Type 2 Diabetes ◽

Visceral Fat ◽

Japanese Patients ◽

Controlled Study ◽

Metabolic Dysfunction ◽

Open Label ◽

Fat Reduction ◽

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

Yearbook of Endocrinology ◽

10.1016/s0084-3741(08)70088-x ◽

2007 ◽

Vol 2007 ◽

pp. 150-154

Author(s):

D.H. Bessesen

Keyword(s):

Type 2 Diabetes ◽

Controlled Study ◽

Obese Patients ◽

Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/j.yobg.2011.05.175 ◽

2011 ◽

Vol 2011 ◽

pp. 15-16

Author(s):

J.S. Dungan

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Low Dose ◽

Controlled Study ◽

Double Blind ◽

Dose Combination ◽

Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay®) on glycaemic control in type 1 and type 2 diabetes patients

Diabetes & Metabolism ◽

10.1016/j.diabet.2009.02.006 ◽

2009 ◽

Vol 35 (4) ◽

pp. 312-318 ◽

Cited By ~ 25

Author(s):

E. Cosson ◽

E. Hamo-Tchatchouang ◽

L. Dufaitre-Patouraux ◽

J.-R. Attali ◽

J. Pariès ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Glucose Monitoring ◽

Controlled Study ◽

Randomised Controlled ◽

The Impact ◽

Diabetes Patients

Review for "Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomised controlled study (PRIME‐V study)"

10.1111/dom.13750/v2/review3 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Visceral Fat ◽

Japanese Patients ◽

Controlled Study ◽

Metabolic Dysfunction ◽

Open Label ◽

Fat Reduction ◽

Review for "Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomised controlled study (PRIME‐V study)"

10.1111/dom.13750/v2/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Visceral Fat ◽

Japanese Patients ◽

Controlled Study ◽

Metabolic Dysfunction ◽

Open Label ◽

Fat Reduction ◽

Review for "Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomised controlled study (PRIME‐V study)"

10.1111/dom.13750/v1/review2 ◽

2019 ◽

Author(s):

Zhengxiang Huang

Keyword(s):

Type 2 Diabetes ◽

Visceral Fat ◽

Japanese Patients ◽

Controlled Study ◽

Metabolic Dysfunction ◽

Open Label ◽

Fat Reduction ◽

Telemonitoring in fasting individuals with Type 2 Diabetes Mellitus during Ramadan: A prospective, randomised controlled study

Scientific Reports ◽

10.1038/s41598-017-10564-y ◽

2017 ◽

Vol 7 (1) ◽

Cited By ~ 5

Author(s):

Jun Yang Lee ◽

Chee Piau Wong ◽

Christina San San Tan ◽

Nazrila Hairizan Nasir ◽

Shaun Wen Huey Lee

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Controlled Study ◽